生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Benzamide (Benzenecarboxamide) is a potent poly(ADP-ribose) polymerase (PARP) inhibitor. Benzamide has protective activity against both glutamate- and methamphetamine (METH)-induced neurotoxicity in vitro. Benzamide can attenuate the METH-induced dopamine depletions and exhibits neuroprotective activity in mice, also has no acute effect on striatal dopamine metabolism and does not reduce body temperature. Benzamide (160 mg/kg; IP, 2 injection by a 4 h interval) attenuates the METH-induced dopamine depletions. Benzamide (160 mg/kg; IP, single dosage) has no acute effect on striatal dopamine metabolism and does not reduce body temperature[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01636947 | Nausea Vomiti... 展开 >>ng 收起 << | Phase 4 | Completed | - | - |
NCT01636947 | - | Completed | - | - | |
NCT00080444 | Vomiting | Phase 3 | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
8.26mL 1.65mL 0.83mL |
41.28mL 8.26mL 4.13mL |
82.55mL 16.51mL 8.26mL |
参考文献 |
---|